Kay L. Wanke

769 total citations
15 papers, 354 citations indexed

About

Kay L. Wanke is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Health. According to data from OpenAlex, Kay L. Wanke has authored 15 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Health. Recurrent topics in Kay L. Wanke's work include Smoking Behavior and Cessation (7 papers), Nutritional Studies and Diet (3 papers) and Health disparities and outcomes (2 papers). Kay L. Wanke is often cited by papers focused on Smoking Behavior and Cessation (7 papers), Nutritional Studies and Diet (3 papers) and Health disparities and outcomes (2 papers). Kay L. Wanke collaborates with scholars based in United States, India and Germany. Kay L. Wanke's co-authors include Erik Augustson, Lila J. Finney Rutten, Neil E. Caporaso, Andrew W. Bergen, Nilanjan Chatterjee, Elaine Lanza, Phil R. Taylor, Demetrius Albanes, Leah B. Sansbury and Scott D. Rogers and has published in prestigious journals such as American Journal of Epidemiology, American Journal of Public Health and Journal of Nutrition.

In The Last Decade

Kay L. Wanke

15 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kay L. Wanke United States	8	192	106	79	50	44	15	354
Beth Edwards Canada	11	164 0.9×	165 1.6×	56 0.7×	77 1.5×	45 1.0×	20	353
Amelia Yazidjoglou Australia	9	170 0.9×	97 0.9×	41 0.5×	71 1.4×	39 0.9×	16	345
Kerstin Schotte Switzerland	8	172 0.9×	89 0.8×	57 0.7×	20 0.4×	19 0.4×	14	313
Jacqui Drope United States	4	231 1.2×	63 0.6×	70 0.9×	52 1.0×	46 1.0×	5	379
Cheryl Rivard United States	13	220 1.1×	146 1.4×	65 0.8×	21 0.4×	67 1.5×	29	438
Krzysztof Buczkowski Poland	9	155 0.8×	48 0.5×	47 0.6×	18 0.4×	40 0.9×	39	320
K. Michael Cummings United States	3	235 1.2×	93 0.9×	45 0.6×	29 0.6×	101 2.3×	3	324
Carol Rosenblum United States	7	275 1.4×	117 1.1×	52 0.7×	159 3.2×	90 2.0×	9	487
Katharine Bowker United Kingdom	13	366 1.9×	68 0.6×	64 0.8×	30 0.6×	73 1.7×	16	413
Wade K. Copeland United States	11	88 0.5×	85 0.8×	96 1.2×	74 1.5×	73 1.7×	15	415

Countries citing papers authored by Kay L. Wanke

Since Specialization

Citations

This map shows the geographic impact of Kay L. Wanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay L. Wanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay L. Wanke more than expected).

Fields of papers citing papers by Kay L. Wanke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay L. Wanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay L. Wanke. The network helps show where Kay L. Wanke may publish in the future.

Co-authorship network of co-authors of Kay L. Wanke

This figure shows the co-authorship network connecting the top 25 collaborators of Kay L. Wanke. A scholar is included among the top collaborators of Kay L. Wanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay L. Wanke. Kay L. Wanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sharma, Kriti, et al.. (2023). Impact of National Institutes of Health and Food and Drug Administration Tobacco Research Funding: A Bibliometrics Analyses. Nicotine & Tobacco Research. 25(6). 1082–1089. 4 indexed citations

Meissner, Helen I., et al.. (2021). NIH Tobacco Research and the Emergence of Tobacco Regulatory Science. Nicotine & Tobacco Research. 24(4). 463–468. 3 indexed citations

Swan, Gary E., Tabitha Hendershot, Carol M. Hamilton, Dana M. van Bemmel, & Kay L. Wanke. (2020). The PhenX Toolkit: measures for tobacco regulatory research. Tobacco Control. 29(Suppl 1). s1–s4. 2 indexed citations

Garcı́a-Cazarı́n, Mary L., et al.. (2018). Host–agent–vector–environment measures for electronic cigarette research used in NIH grants. Tobacco Control. 29(Suppl 1). tobaccocontrol–2017. 5 indexed citations

Walton, Kevin M., David B. Abrams, William C. Bailey, et al.. (2014). NIH Electronic Cigarette Workshop: Developing a Research Agenda. Nicotine & Tobacco Research. 17(2). 259–269. 88 indexed citations

Wanke, Kay L. & Michael Spittel. (2011). Advancing Research in Gene–Environment Interplay: Can Developmental Science Lead the Way?. Research in Human Development. 8(3-4). 165–172. 5 indexed citations

Sansbury, Leah B., Kay L. Wanke, Paul S. Albert, et al.. (2009). The Effect of Strict Adherence to a High-Fiber, High-Fruit and -Vegetable, and Low-Fat Eating Pattern on Adenoma Recurrence. American Journal of Epidemiology. 170(5). 576–584. 44 indexed citations

Wanke, Kay L., Cassandra Daston, Paul S. Albert, et al.. (2007). Adherence to the Polyp Prevention Trial Dietary Intervention Is Associated with a Behavioral Pattern of Adherence to Nondietary Trial Requirements and General Health Recommendations1,2. Journal of Nutrition. 137(2). 391–398. 14 indexed citations

Augustson, Erik, Kay L. Wanke, Scott D. Rogers, et al.. (2007). Predictors of Sustained Smoking Cessation: A Prospective Analysis of Chronic Smokers From the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. American Journal of Public Health. 98(3). 549–555. 76 indexed citations

10.

Sansbury, Leah B., Andrew W. Bergen, Kay L. Wanke, et al.. (2006). Inflammatory Cytokine Gene Polymorphisms, Nonsteroidal Anti-Inflammatory Drug Use, and Risk of Adenoma Polyp Recurrence in the Polyp Prevention Trial. Cancer Epidemiology Biomarkers & Prevention. 15(3). 494–501. 21 indexed citations

11.

Rutten, Lila J. Finney, Erik Augustson, & Kay L. Wanke. (2006). Factors Associated with Patients' Perceptions of Health Care Providers' Communication Behavior. Journal of Health Communication. 11(sup001). 135–146. 62 indexed citations

12.

Wanke, Kay L., et al.. (2005). Systems and Individual Factors Associated With Smoking Status: Evidence From HINTS. American Journal of Health Behavior. 29(4). 302–310. 16 indexed citations

13.

Knowles, John H., Kay L. Wanke, & Ichiro Kawachi. (2004). Internet Sales of Tobacco: Heading Off the New E-pidemic. Journal of Public Health Policy. 25(2). 162–172. 12 indexed citations

14.

Wobrock, Thomas, Bernhard Schwaab, Michael Böhm, et al.. (2001). Pharmakotherapeutische Behandlungsstrategien der Insomnie bei Patienten mit kardialen Erkrankungen und nach Herztransplantation. Zeitschrift für Kardiologie. 90(10). 717–728. 1 indexed citations

15.

Small, Mark & Kay L. Wanke. (1994). State Responses To Child Maltreatment. Journal of Offender Rehabilitation. 21(1-2). 11–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact